alexa Supercritical Antisolvent (SAS) Assisted Thymoquinone Liposomal Formulation For Radioprotection | 67152
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

8th World congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit

Iqbal Ahmad, Rakesh Kumar Sharma and Farhan Jalees Ahmad
Jamia Hamdard, India
Defence Food Research Laboratory, India
Posters & Accepted Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X-C1-030
Abstract
Exposure of ionizing radiation (IOR) can be through various diagnostic and therapeutic processes or inadvertently through nuclear accidents. Lethality of IOR is predominantly linked with generation of reactive oxygen species (ROS), apart from direct deleterious effects on antioxidants and antioxidant enzymes. ROS can readily react with cellular lipids, proteins and DNA to cause irreversible cellular damage and cascading pathogenesis. Thymoquinone (TQ) or 2-Isopropyl-5-methyl-1,4- benzoquinone, obtained from seeds of Nigella sativa (Ranunculaceae) has strong antioxidant effect and is proven to defend against oxidative damage. Moreover, in vivo studies also highlighted the potential of Nigella sativa extract against radiation induced injuries. Nevertheless, due to poor aqueous solubility and rapid elimination rate, the full potential of TQ is not exploited. This study was to develop SAS assisted TQ loaded PEGylated liposome for enhanced blood circulation, improved bioavailability and greater radioprotection. Supercritical antisolvent (SAS) process was optimized by QbD approach and characterized. The radioprotective efficacy of the developed formulation was compared with pure drug solution and amifostine (FDA approved radioprotector) administered through i.v. route post gamma radiation exposure on Swiss albino strain ‘A’ mice. SAS process (Temperature=35°C; pressure=140 bar and solution flow rate=0.18 mL/min, phospholipid=7.5 mMole, cholesterol= 0.75 mMole and TQ=1 mMole, 5% DSPE-mPEG-2000) produced spherical optimized liposome (FV-17B) with particle size of 231.3±6.74 nm and entrapment efficiency of 89.4±3.69%. In vivo study showed that non-significant body weight change, increased survival probability, normalization of hematological parameters, spleen index and frequency of micronucleus cells in bone marrow apart from least DNA damage was observed after administration of FV-17B post 7Gy of whole body irradiation as compared to irradiation control as well as amifostine group. Thus, the developed formulation could be a suitable non-toxic alternative against damage during radiotherapy.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version